CT Children's Medical CTR. Cash Balance Retirement

CT Children's Medical CTR. Cash Balance Retirement

The Cash Balance Retirement plan serves as the defined-benefit vehicle for Connecticut Children's Medical Center, a Hartford-based institution founded in 1994 and anchored by its main campus at 282 Washington Street. The plan is noncontributory, covering employees of the CCMC Corporation parent entity, which operates under President and CEO James E. Shmerling and CFO Bridgett Feagin. While the hospital's clinical and research partnerships — including ties to Hartford HealthCare, UConn Health, and The Jackson Laboratory — shape its regional profile, the retirement plan's investment activity reflects a narrower mission: stable, balanced returns for hospital staff. The plan's asset mix draws on equity and multi-asset balanced mutual funds, including foreign balanced funds and limited partnership interests. Its investment posture is conservative, consistent with a noncontributory defined-benefit structure where funding obligations fall on the sponsoring employer rather than on employees. Geographic exposure spans domestic U.S. markets and select international allocations through foreign balanced funds. Total plan assets are estimated by Altss at roughly $81 million, a figure that places the plan in the small-pension bracket relative to statewide peers. The plan's governance is embedded within the CCMC Corporation's broader finance function rather than a standalone investment office; there is no evidence of dedicated pension investment staff or a public investment committee. The parent organization's real-estate footprint — including the main campus, a new clinical tower, administrative headquarters at Hartford Square North, and off-site facilities in Farmington and East Hartford — represents a major balance-sheet asset, though the retirement plan's direct real-estate exposure is not separately itemized in public filings. Structurally, the plan differs from most institutional allocators in that it functions as an internal employee benefit rather than as a public or corporate pension fund with independent governance. No recent material operational events — such as plan amendments, fiduciary changes, or asset-liability studies — have been publicly reported in the last 24 months.